(Reuters) - Pfizer Inc. is in early-stage talks to acquire cancer drugmaker Seagen Inc in what could be a multi-billion dollar deal, The Wall Street Journal reported, citing people familiar with the matter.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
